
Illustrative image. Catalogue strength: 10 mg / 10 mg; image label may differ.
BPC-157/TB-500 Blend
A blended reference material containing BPC-157 and TB-500 (thymosin beta-4 fragment), supplied for in-vitro laboratory research.
- Material
- BPC-157/TB-500 Blend
- Form
- Lyophilized powder
- Vial quantity
- 10 mg / 10 mg · 1 vial
- Batch number
- BLD-502
- Testing status
- Report published
- Storage
- Store lyophilized material at -20 °C, protected from light. Once reconstituted, refrigerate at 2–8 °C and handle under standard laboratory practice.
Supplied for laboratory research use only. Not for human or veterinary use.
Latest Test Results
Batch: BLD-502
- Identity
- Reported components: BPC-157 and Thymosin β4 (HPLC-MS/MS).
- Quantity
- BPC-157: 12.14 mg; Thymosin β4: 11.85 mg; total net content: 23.99 mg (tested sample).
- Purity
- BPC-157: 99.71%; Thymosin β4: 99.70% chromatographic purity (tested sample).
- Additional testing
- No endotoxin or sterility results supplied.
- Independent laboratory
- Peptide Test Canada / Side-Chain Analytics Inc.
- Testing date
- November 5, 2026
Laboratory sample ID BLD-502; report COA-2026-SC-04742; verification reference PTC-87JHUVCY. Received October 29, 2026; analyzed and reported November 5, 2026. This record uses the laboratory sample ID, not a confirmed inventory lot number. The laboratory names the second component Thymosin β4. Results apply only to the sample as received, not other vials or any entire lot or batch. They do not establish safety, efficacy, regulatory compliance, or suitability for human or veterinary use. Laboratory permission to display the full report was confirmed by the owner.
Batch archive
- BLD-502November 5, 2026View record →
- LAN-BT-2608-01—View record →
Material Overview
BPC-157 / TB-500 is supplied as a blended peptide reference material. BPC-157 is a synthetic pentadecapeptide sequence derived from a gastric protein fragment; TB-500 refers to a synthetic peptide related to thymosin beta-4. The blend is prepared for laboratory research use and each batch is submitted for independent analytical testing.
Research Context
BPC-157 and thymosin beta-4 related peptides have been examined in preclinical literature in the context of cellular migration, angiogenesis signalling and tissue-model studies. Published work is largely preclinical and does not establish clinical efficacy.
Storage & Handling
Store lyophilized material at -20 °C, protected from light. Once reconstituted, refrigerate at 2–8 °C and handle under standard laboratory practice.
Molecular Information
- Peptide sequence
- BPC-157: GEPPPGKPADDAGLV
- Molecular formula
- BPC-157: C62H98N16O22
- Molecular weight
- BPC-157: 1419.53 g/mol
- CAS number
- 137525-51-0 (BPC-157)
- Synonyms
- Body Protection Compound 157; Thymosin beta-4 fragment
- Research classification
- Peptide blend reference material
Common questions about BPC-157/TB-500 Blend
- What purity is BPC-157/TB-500 Blend tested to?
- Our specification is Reported per batch. Each lot's sample is sent to an independent third-party laboratory, and published reports apply only to the sample tested.
- How should BPC-157/TB-500 Blend be stored?
- Store lyophilized material at -20 °C, protected from light. Once reconstituted, refrigerate at 2–8 °C and handle under standard laboratory practice.
- What strength and form is supplied?
- 10 mg / 10 mg per vial, supplied as lyophilized powder.
- Where does BPC-157/TB-500 Blend ship from?
- Orders are processed and dispatched within Canada. Shipping is $22 CAD on orders under $300 and free at $300 or more.
- Is BPC-157/TB-500 Blend for human use?
- No. It is sold strictly for laboratory research use only and is not for human or veterinary consumption.
